Back to School: How biopharma can reboot drug development. Access exclusive analysis here

The fate of NK cells

Differentiation states of CAR-transfected NK cells influence anticancer function

New research is elucidating the relationship between CAR-transfected NK cells’ differentiation states and their cancer-killing potential -- knowledge that Fate Therapeutics Inc. (NASDAQ:FATE) is leveraging for its own cell therapies.

In a study published in Cancer Immunology Research, a team that included Karl-Johan “Kalle” Malmberg explored how dynamic expression of various NK cell receptors affects the magnitude of the cells’ degranulation against tumor cell targets. Expression levels of these receptors change as highly

Read the full 725 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers